TABLE 2.
Comparison of outcome parameters between participants with (Dep+) and without history of unipolar depression (Dep–).
| Parameters | Dep- | Dep+ | Between subject effect | Within subject effect | ||||
| P-value | F value | Effect size | P-value | F value | Effect size | |||
| Mean gait speed (m/min) | 101 ± 13 | 98 ± 11 | 0.048* | 3.40 | 0.09 | 0.36 | 1.35 | 0.00 |
| MDS UPDRS III (0–132) | 1.8 ± 0.3 | 1.8 ± 0.3 | 0.11 | 1.92 | 0.01 | 0.57 | 0.45 | 0.00 |
| CERAD (0–100) | 85.4 ± 7.1 | 84.4 ± 8.0 | 0.65 | 1.26 | 0.00 | 0.49 | 0.62 | 0.01 |
| MMST (0–30) | 28.6 ± 0.9 | 28.6 ± 0.9 | 0.83 | 0.00 | 0.00 | 0.25 | 1.36 | 0.00 |
| DTC (%) | +1.0 ± 0.5 | +1.0 ± 0.5 | 0.65 | 0.34 | 0.00 | 0.52 | 0.64 | 0.00 |
Mean values are presented for all timepoints. CERAD, Consortium to Establish a Registry for Alzheimer’s disease; Dep-, negative history of unipolar depression; Dep+, positive history of unipolar depression; DTC, dual task cost for checking boxes during walking; MDS-UPDRS III, Movement Disorder Society Unified Parkinson disease rating scale III; MMST, Mini-Mental-State Examination.
*p-value < 0.05.